Next-gen sequencing: Why gene research delivers returns to investors
Rapid developments in genetic sequencing by the world’s top researchers has the potential to create healthier lives and revolutionise medical treatment. Investing in sustainable technology is central to Hermes Impact Opportunities Fund’s investment strategy.
Advanced genetic sequencing may be capable of fulfilling one of the greatest promises in medical treatment. It aims to decipher the human genome – our body’s complete set of genetic information – thereby supporting breakthroughs in medical research and treatment. As such, companies leading in this field are aligned with the Hermes Impact Opportunities Fund’s Health and Wellbeing investment theme.
Since a human genome was sequenced for the first time in 2003, researchers have gaine…
Please sign in or register
for free access to 1 article per month from AsianInvestor’s content and archives of over 16,000 articles.
¬ Haymarket Media Limited. All rights reserved.